P36639 (8ODP_HUMAN) Homo sapiens (Human)

Oxidized purine nucleoside triphosphate hydrolase UniProtKBInterProSTRINGInteractive Modelling

156 aa; Sequence (Fasta) ; (Isoform 1; Isoform 2; Isoform 3); 1 identical sequence: Pongo abelii: A0A6D2XCX3

Available Structures

107 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
MTH1 in complex with TH013071
8a34
homo-2-mer1-156
2×KYI; 1×ACT; 6×SO4;
Assess
Crystal structure of NUDT1 (MTH1) with S-crizotinib
4c9x
homo-2-mer3-156
2×VHS; 2×CL; 10×SO4;
Assess
Crystal structure of NUDT1 (MTH1) with R-crizotinib
4c9w
homo-2-mer3-156
2×CL; 2×VGH; 10×SO4;
Assess
Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 2-oxo-dATP
5ws7
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 8-oxo-dGTP determined using …
6ijy
monomer1-156
1×8DG; 3×NA; 2×GOL;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.6
8i1f
monomer1-156
1×6U4; 4×NA;
Assess
Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 9.7
8i1j
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 7.7
8i18
monomer1-156
1×8DG; 2×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.0
8i1e
monomer1-156
1×6U4; 3×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.7
8i1h
monomer1-156
2×NA; 1×GOL;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.1
8i1g
monomer1-156
1×6U4; 2×NA; 1×GOL;
Assess
Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP under high concentrati…
5ghq
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of human MTH1(G2K/D120A mutant) in complex with 8-oxo-dGTP
5gho
monomer1-156
1×GOL; 1×NA;
Assess
Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP
5ghp
monomer1-156
1×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 7.7
8i1d
monomer1-156
1×6U4; 3×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP
5ghj
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 7.7
8i1i
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP
5ghi
monomer1-156
1×8DG; 2×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dAMP and Mn2+
8i8t
monomer1-156
1×IGU; 3×MN;
Assess
Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP
5ghn
monomer1-156
1×6U4; 2×NA;
Assess
Crystal structure of hMTH1 N33A in complex with LW14 in the presence of acetate
6gll
monomer1-156
1×BU8; 1×SO4; 1×ACT;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.6
8i1a
monomer1-156
1×8DG; 4×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 9.1
8i1c
monomer1-156
3×NA;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGMP and Mn2+
8i8s
monomer1-156
1×8OG; 3×MN;
Assess
Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 6.5
6ili
monomer1-156
1×8DG;
Assess
Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.0
8i19
monomer1-156
1×8DG; 3×NA;
Assess
Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 7.0
5ghm
monomer1-156
1×8DG; 1×NA;
Assess
Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the absence of acetate
6gls
monomer1-156
2×F3E; 4×SO4;
Assess
Complex between MTH1 and compound 29 (a 4-amino-2,7-diazaindole derivative)
6f22
monomer1-156
1×C9B; 5×SO4;
Assess
Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the presence of acetate
6glr
monomer1-156
2×F3E; 1×ACT; 3×SO4;
Assess
Crystal structure of hMTH1 N33G in complex with LW14 in the absence of acetate
6glq
monomer1-156
1×BU8; 4×SO4;
Assess
Crystal structure of hMTH1 N33G in the presence of acetate
6glo
monomer1-156
2×SO4;
Assess
Crystal structure of human MTH1 in complex with O6-methyl-dGMP
5otm
monomer1-156
4×SO4; 1×ACT; 1×6OG;
Assess
Complex between MTH1 and compound 16 (a 4-amino-7-azaindole derivative)
6f23
monomer1-156
1×C8Z; 5×SO4; 2×GOL;
Assess
Complex between MTH1 and compound 1 (a 7-azaindole-4-ester derivative)
6f20
monomer1-156
1×C9E; 5×SO4; 2×ACT;
Assess
Solution structure of the hMTH1, a nucleotide pool sanitization enzyme
1iry
monomer1-156
Assess
Crystal structure of hMTH1 F27A in complex with LW14 in the presence of acetate
6glg
monomer2-156
1×BU8; 1×SO4; 1×ACT;
Assess
Crystal structure of MTH1 in complex with compound 32
7n13
monomer2-156
1×ZRV; 2×SO4;
Assess
Potent and selective inhibitors of MTH1 probe its role in cancer cell survival
5ans
monomer2-156
1×RX8;
Assess
Crystal structure of hMTH1 D120N in complex with TH scaffold 1 in the absence of acetate
6glv
monomer2-156
1×F3E; 4×SO4;
Assess
MTH1 in complex with fragment 4
6eq5
monomer2-156
1×AX7; 1×SO4;
Assess
Potent and selective inhibitors of MTH1 probe its role in cancer cell survival
5ant
monomer2-156
1×RJE;
Assess
Crystal structure of MTH1 in complex with compound 31
7n03
monomer3-156
1×ZRP; 2×SO4;
Assess
MTH1 in complex with compound 15
5anv
monomer3-156
1×RGJ;
Assess
Crystal structure of hMTH1 F27A in complex with LW14 in the absence of acetate
6glh
monomer3-156
1×BU8; 2×SO4;
Assess
MTH1 substrate recognition: Complex with a methylaminopurinone
5fsl
monomer3-156
1×UAN; 1×SO4;
Assess
Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the absence of acetate
6glj
monomer3-156
4×SO4; 1×F3E;
Assess
MTH1 in complex with compound 24
5anw
monomer3-156
1×9CQ;
Assess
MTH1 in complex with TH013350
8a0s
monomer3-156
2×KOX; 1×SO4;
Assess
MTH1 in complex with fragment 8
6eq4
monomer3-156
1×BSW; 2×SO4;
Assess
Crystal structure of hMTH1 N33A in complex with TH scaffold 1 in the absence of acetate
6gln
monomer3-156
1×F3E; 4×SO4;
Assess
Crystal structure of hMTH1 in complex with TH scaffold 1 in the presence of acetate
6gle
monomer3-156
1×F3E; 1×SO4;
Assess
MTH1 in complex with compound 4
6us3
monomer3-156
1×8JF;
Assess
MTH1 in complex with fragment 11
6eq7
monomer3-156
1×BS8; 1×SO4;
Assess
Crystal structure of hMTH1 N33A in the presence of acetate
6glk
monomer3-156
3×SO4;
Assess
Crystal structure of human MTH1 in complex with inhibitor 7-(furan-2-yl)-5-methyl-1,3-benzoxazol-2-…
5ngt
monomer3-156
1×8WZ; 2×SO4;
Assess
The Crystal Structure of human MTH1 from Biortus
7esf
monomer3-156
1×PG4; 1×PEG;
Assess
MTH1 substrate recognition: Complex with 8-oxo-dGTP.
5fsk
monomer3-156
1×H6Y; 1×ACT;
Assess
Crystal structure of hMTH1 D120N in the presence of acetate
6glt
monomer3-156
1×DMS;
Assess
Structure of human MTH1 in complex with TH287
4n1t
monomer3-156
1×2GD; 4×SO4;
Assess
MTH1 in complex with TH013074
8a3a
monomer3-156
1×KYR; 1×SO4;
Assess
Crystal structure of hMTH1 N33A in complex with LW14 in the absence of acetate
6glm
monomer3-156
1×BU8; 2×SO4;
Assess
Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the presence of acetate
6gli
monomer3-156
1×F3E;
Assess
MTH1 substrate recognition: Complex with 8-oxo-dGTP.
5fsi
monomer3-156
1×8DG;
Assess
MTH1 substrate recognition: Complex with a methylbenzimidazolyl acetamide.
5fsm
monomer3-156
1×ACT; 1×N91; 3×DMS;
Assess
MTH1 substrate recognition: Complex with a methylaminopyrimidinedione.
5fso
monomer3-156
1×ACT; 1×S76; 2×DMS;
Assess
MTH1 substrate recognition: Complex with a aminomethylpyrimidinyl oxypropanol.
5fsn
monomer3-156
1×6Q3; 1×ACT; 1×DMS;
Assess
Crystal structure of hMTH1 D120N in complex with LW14 in the presence of acetate
6glu
monomer3-156
1×BU8;
Assess
BAY-707 in complex with MTH1
5nhy
monomer3-156
1×8XT; 6×SO4; 1×GOL;
Assess
Crystal structure of human apo MTH1
6jvf
monomer3-156
Assess
MTH1 in complex with fragment 9
6eq3
monomer3-156
1×BU5; 1×SO4;
Assess
Crystal structure of human MTH1 in complex with 8-oxo-dGMP
3zr0
monomer3-156
1×8OG; 2×SO4;
Assess
MTH1 in complex with compound 15
5anu
monomer3-156
1×DMS; 1×58T;
Assess
Crystal Structure of Human 8-oxo-dGTPase (MTH1)
3q93
monomer3-156
3×SO4; 1×IMD; 2×GOL;
Assess
MTH1 in complex with compound 5
6us2
monomer3-156
1×S3O;
Assess
Crystal structure of human MTH1 in complex with compound MI1030
6jvt
monomer3-156
1×CJR;
Assess
MTH1 in complex with fragment 6
6eq2
monomer3-156
1×BU8;
Assess
Crystal structure of human MTH1 in complex with compound MI0639
6jvg
monomer3-156
1×95F;
Assess
Crystal structure of human MTH1 in complex with inhibitor 6-[(2-phenylethyl)sulfanyl]-7H-purin-2-am…
5ngs
monomer3-156
1×8WW; 6×SO4; 1×ACT;
Assess
Crystal structure of MTH1 in complex with alpha-mangostin (cocktail No. 9)
6aa4
monomer3-156
2×ZN; 1×MKS; 1×SO4;
Assess
MTH1 in complex with TH012532
8a0t
monomer3-156
1×KLO; 1×GOL; 6×SO4;
Assess
Complex between MTH1 and compound 7 (a 7-azaindole-2-amide derivative)
6f1x
monomer3-156
1×C9Q; 3×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI1014
6jvl
monomer3-156
1×CG0;
Assess
Crystal structure of human MTH1
3zr1
monomer3-156
1×ACT; 3×SO4;
Assess
Crystal structure of MTH1 in complex with 3-isomangostin
6aa5
monomer3-156
1×MKU; 3×ZN; 1×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI1022
6jvo
monomer3-156
1×CJ6;
Assess
MTH1 in complex with compound 32
6us4
monomer3-156
1×GN6;
Assess
Crystal structure of hMTH1 F27A in the presence of acetate
6glf
monomer3-156
Assess
Crystal structure of MTH1 in apo form (cocktail No. 1)
6aa3
monomer3-156
3×ZN; 1×SO4;
Assess
MTH1 in complex with fragment 1
6eq6
monomer3-156
1×EV2; 1×ACT; 1×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI0320
6jvh
monomer3-156
1×95L;
Assess
Crystal structure of human MTH1 in complex with compound MI1016
6jvm
monomer3-156
1×CGX;
Assess
Crystal structure of human MTH1 in complex with compound MI1029
6jvs
monomer3-156
1×CJL;
Assess
Crystal structure of MTH1 in complex with 18-Crown-6
6imz
monomer3-156
3×ZN; 1×SO4; 2×O4B; 1×VGH;
Assess
Crystal structure of human MTH1 in complex with compound MI1012
6jvk
monomer3-156
1×CEU;
Assess
Crystal structure of human MTH1 in complex with compound MI1020
6jvn
monomer3-156
1×CJ0;
Assess
MTH1 in complex with TH001969
8a07
monomer3-156
1×L3N; 3×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI1025
6jvq
monomer3-156
1×CJF;
Assess
Crystal structure of human MTH1 in complex with fragment inhibitor 8-(methylsulfanyl)-7H-purin-6-am…
5ngr
monomer3-156
1×8WT; 4×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI1024
6jvp
monomer3-156
1×CJ9;
Assess
Crystal structure of human MTH1 in complex with compound MI0861
6jvi
monomer3-156
1×95R; 1×SO4;
Assess
Crystal structure of human MTH1 in complex with compound MI1026
6jvr
monomer3-156
1×CJU;
Assess
Crystal structure of human MTH1 in complex with compound MI1006
6jvj
monomer3-156
1×C9L;
Assess
Crystal structure of human MTH1 in complex with N6-methyl-dAMP
6qvo
monomer3-156
3×SO4; 1×6MA;
Assess
MTH1 in complex with Ruthenium-based inhibitor
3whw
monomer3-156
3×SO4; 1×RUX;
Assess
Crystal structure of hMTH1 N33G in complex with LW14 in the presence of acetate
6glp
monomer1-153
1×BU8; 2×SO4; 1×ACT;
Assess
Structure of human MTH1 in complex with TH588
4n1u
monomer3-155
1×2GE; 7×SO4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3q93.1.Amonomer0.893-156
1×IMD;100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 16qvo.1.Amonomer0.8844-197
1×6MA;100.00
Assess
Isoform 26qvo.1.Amonomer0.8926-179
1×6MA;100.00
Assess
Isoform 36qvo.1.Amonomer0.8918-171
1×6MA;100.00
Assess